Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary

Chronoscale

28/04/2022 23:36

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 36 cents​​ per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of 41 cents per share.
    * Revenue rose 34.4% to $2.57 million from a year ago; 
analysts
expected $3.20 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 36 cents​.
    * The mean earnings estimate of analysts had fallen by
about 64%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had fallen by 15.2% this
quarter and lost 7.5% so far this year.
    * The company reported a quarterly loss of $4.62 million.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 28 at 10:36 p.m.  ​All
figures in US dollars unless otherwise stated